Next-Level Diagnostics with the EXENT® System: Built for the Lab. Designed for the Clinic. Focused on the Patient.

Wednesday, July 29
10:15 – 11:15 a.m.
Exhibit Hall Theater 1
Presented by Thermo Fisher Scientific

Overview

This session examines current MG assessment practices and challenges, with a practical focus on M-protein measurement in blood and its impact on analytical confidence and clinical decision-making. Attendees will discover how the EXENT® System applies mass spectrometry in a purpose-built, automated solution—streamlining workflows, improving specificity, and enabling the lab to deliver clearer answers for clinicians and patients alike.

Outcome

1. Review laboratory practices of monoclonal gammopathy (MG) assessment including the current challenges and opportunities
2. Learn about M-protein measurement in the blood and how this impacts laboratory and clinical decisions
3. Understand how mass spectrometry impacts the future of MG assessment

Moderator

Jill Pauli, PhD
Associate Director, Scientific Affairs
Binding Site, part of Thermo Fisher Scientific

Speakers

Steven Conklin-Lopez
Technical Director
LabCorp

Dr. Shelby Hutcherson
Clinical Chemist
Beth Israel Deaconess Medical Center